High levels of adenosine deaminase on dendritic cells promote autoreactive T cell activation and diabetes in nonobese diabetic mice

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 6798-6806

  Oskouie, Faranak Ghaemi ^a,b   Shameli, Afshin ^a,b   Yang, Ailian ^a,b   Desrosiers, Melanie D ^a,b   Mucsi, Ashley D ^a,b   Blackburn, Michael R ^c   Yang, Yang ^a,b   Santamaria, Pere ^a,b   Shi, Yan ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADENOSINE DEAMINASE; ANIMALS; AUTOIMMUNITY; DENDRITIC CELLS; DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; T-LYMPHOCYTES;

EID: 79959551775     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1004222     Document Type: Article

References (40)

1. Rock, K. L., A. Hearn, C. J. Chen, and Y. Shi. 2005. Natural endogenous adjuvants. Springer Semin. Immunopathol. 26: 231-246.
2. Haskó, G., and B. N. Cronstein. 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25: 33-39.
3. Haskó, G., J. Linden, B. Cronstein, and P. Pacher. 2008. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7: 759-770.
4. Borsellino, G., M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Höpner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al. 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232. (Pubitemid 47281420)
5. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265.
6. Huang, S., S. Apasov, M. Koshiba, and M. Sitkovsky. 1997. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 1600-1610. (Pubitemid 27355433)
7. Lappas, C. M., J. M. Rieger, and J. Linden. 2005. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J. Immunol. 174: 1073-1080. (Pubitemid 40094304)
8. Lappas, C. M., Y. J. Day, M. A. Marshall, V. H. Engelhard, and J. Linden. 2006. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J. Exp. Med. 203: 2639-2648.
9. Desrosiers, M. D., K. M. Cembrola, M. J. Fakir, L. A. Stephens, F. M. Jama, A. Shameli, W. Z. Mehal, P. Santamaria, and Y. Shi. 2007. Adenosine deamination sustains dendritic cell activation in inflammation. J. Immunol. 179: 1884-1892.
10. Flach, T. L., W. Pang, E. M. Chau, M. D. Desrosiers, and Y. Shi. 2009. Adenosine primes resting stage dendritic cells before their activation. Biochem. Biophys. Res. Commun. 380: 748-751.
11. Haskó, G., D. G. Kuhel, J. F. Chen, M. A. Schwarzschild, E. A. Deitch, J. G. Mabley, A. Marton, and C. Szabó . 2000. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14: 2065-2074.
12. Németh, Z. H., C. S. Lutz, B. Csóka, E. A. Deitch, S. J. Leibovich, W. C. Gause, M. Tone, P. Pacher, E. S. Vizi, and G. Haskó. 2005. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J. Immunol. 175: 8260-8270. (Pubitemid 41798391)
13. Dong, R. P., J. Kameoka, M. Hegen, T. Tanaka, Y. Xu, S. F. Schlossman, and C. Morimoto. 1996. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J. Immunol. 156: 1349-1355. (Pubitemid 26065841)
14. Mart?́n, M., J. Huguet, J. J. Centelles, and R. Franco. 1995. Expression of ectoadenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J. Immunol. 155: 4630-4643.
15. Yang, A., A. D. Mucsi, M. D. Desrosiers, J. F. Chen, J. B. Schnermann, M. R. Blackburn, and Y. Shi. 2010. Adenosine mediated desensitization of cAMP signaling enhances T-cell responses. Eur. J. Immunol. 40: 449-459.
16. Greiner, D. L., A. A. Rossini, and J. P. Mordes. 2001. Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere. Clin. Immunol. 100: 134-143.
17. Yang, Y., and P. Santamaria. 2006. Lessons on autoimmune diabetes from animal models. Clin. Sci. 110: 627-639.
18. Rock, K. L., and L. Shen. 2005. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207: 166-183.
19. Scaglia, L., C. J. Cahill, D. T. Finegood, and S. Bonner-Weir. 1997. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138: 1736-1741. (Pubitemid 27137129)
20. Turley, S., L. Poirot, M. Hattori, C. Benoist, and D. Mathis. 2003. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 198: 1527-1537.
21. Blackburn, M. R., M. Aldrich, J. B. Volmer, W. Chen, H. Zhong, S. Kelly, M. S. Hershfield, S. K. Datta, and R. E. Kellems. 2000. The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities. J. Biol. Chem. 275: 32114-32121.
22. Ciruela, F., C. Saura, E. I. Canela, J. Mallol, C. Lluis, and R. Franco. 1996. Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett. 380: 219-223. (Pubitemid 26063938)
23. Herrera, C., V. Casadó, F. Ciruela, P. Schofield, J. Mallol, C. Lluis, and R. Franco. 2001. Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol. Pharmacol. 59: 127-134.
24. Anderson, B., B. J. Park, J. Verdaguer, A. Amrani, and P. Santamaria. 1999. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 96: 9311-9316.
25. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186: 1663-1676.
26. Blackburn, M. R., S. K. Datta, and R. E. Kellems. 1998. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J. Biol. Chem. 273: 5093-5100.
27. Apasov, S. G., M. R. Blackburn, R. E. Kellems, P. T. Smith, and M. V. Sitkovsky. 2001. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J. Clin. Invest. 108: 131-141.
28. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920. (Pubitemid 34024743)
29. Németh, Z. H., D. Bleich, B. Csóka, P. Pacher, J. G. Mabley, L. Himer, E. S. Vizi, E. A. Deitch, C. Szabó, B. N. Cronstein, and G. Haskó. 2007. Adenosine receptor activation ameliorates type 1 diabetes. FASEB J. 21: 2379-2388. (Pubitemid 47230668)
30. Wilson, J. M., W. G. Ross, O. N. Agbai, R. Frazier, R. A. Figler, J. Rieger, J. Linden, and P. B. Ernst. 2009. The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J. Immunol. 182: 4616-4623.
31. Shi, Y., J. E. Evans, and K. L. Rock. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
32. Shi, Y., W. Zheng, and K. L. Rock. 2000. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 97: 14590-14595.
33. Shi, Y., S. A. Galusha, and K. L. Rock. 2006. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J. Immunol. 176: 3905-3908.
34. Gagnerault, M. C., J. J. Luan, C. Lotton, and F. Lepault. 2002. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 196: 369-377.
35. Dahlén, E., K. Dawe, L. Ohlsson, and G. Hedlund. 1998. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J. Immunol. 160: 3585-3593. (Pubitemid 28164755)
36. Csóka, B., L. Himer, Z. Selmeczy, E. S. Vizi, P. Pacher, C. Ledent, E. A. Deitch, Z. Spolarics, Z. H. Németh, and G. Haskó. 2008. Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J. 22: 3491-3499.
37. Green, A. 1987. Adenosine receptor down-regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist. J. Biol. Chem. 262: 15702-15707.
38. Ismail, N. A., E. E. El Denshary, and W. Montague. 1977. Adenosine and the regulation of insulin secretion by isolated rat islets of Langerhans. Biochem. J. 164: 409-413. (Pubitemid 8105678)
39. Kameoka, J., T. Tanaka, Y. Nojima, S. F. Schlossman, and C. Morimoto. 1993. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261: 466-469. (Pubitemid 23276554)
40. Pacheco, R., J. M. Martinez-Navio, M. Lejeune, N. Climent, H. Oliva, J. M. Gatell, T. Gallart, J. Mallol, C. Lluis, and R. Franco. 2005. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc. Natl. Acad. Sci. USA 102: 9583-9588.